Product Information
BENZONATATE 100 MG CAPSULE is a generic product labeled by Chartwell RX LLC, priced at $0.0656 per EA under NDC 62135044031. Its NADAC has been published 183 times since Apr 5, 2023.
FDA first approved this application on Jul 30, 2007. Its Orange Book therapeutic-equivalence code is AA.
Strength
100 mg/1
Manufacturer
Chartwell RX LLCNDC
62135044031
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
BENZONATATEApproval Type
Generic (ANDA)
FDA Application
ANDA040682FDA Approved
7/30/2007
TE Code
AA
On Market Since
5/1/2018
Pharmacological Classes
Price Statistics
The NADAC for BENZONATATE 100 MG CAPSULE has been published 183 times since Apr 5, 2023, and over the history we have for it it has declined 19.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0656 per EA |
|---|---|
| All-time high | $0.0934 (Feb 14, 2024) |
| All-time low | $0.0522 (Nov 20, 2024) |
| 52-week high | $0.0732 |
| 52-week low | $0.0656 |
| Median price | $0.0743 |
| Average price | $0.0744 |
| Largest weekly change | -31.1% (Nov 20, 2024) |
| Weeks tracked | 183 |
| Tracking since | Apr 5, 2023 |
Generic Alternatives
The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chartwell RX LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Benzonatate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Non-narcotic Antitussive class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BENZONATATE 100 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for BENZONATATE 100 MG CAPSULE, manufactured by Chartwell RX LLC, is $0.0656 per EA (NDC 62135044031), effective Sep 30, 2026.
How has the price of BENZONATATE 100 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for BENZONATATE 100 MG CAPSULE has declined 19.4%. It has been tracked across 183 weekly CMS publications since Apr 5, 2023.
What are the highest and lowest recorded NADAC prices for BENZONATATE 100 MG CAPSULE?
Since Apr 5, 2023, the NADAC for BENZONATATE 100 MG CAPSULE has ranged from a low of $0.0522 (Nov 20, 2024) to a high of $0.0934 (Feb 14, 2024), with a median of $0.0743 per EA.
Are there cheaper alternatives to BENZONATATE 100 MG CAPSULE?
12 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BENZONATATE 100 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures BENZONATATE 100 MG CAPSULE?
BENZONATATE 100 MG CAPSULE (NDC 62135044031) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.